Form 4 for ELUT ELUTIA INC.
Accepted 2022-03-10 00:00:00 ET · period of report 2022-03-08 · accession 0001415889-22-002868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-10 | 2022-03-08 | ELUT | Englese Thomas | Chief COMMERCIAL Off | M - OptEx | $0.00 | +938 | 6,883 | +16% | $0 |
| D | 2022-03-10 | 2022-03-10 | ELUT | Englese Thomas | Chief COMMERCIAL Off | S - Sale+OE | — | -276 | 6,607 | -4% | — |
| D | 2022-03-10 | 2022-03-08 | ELUT | Englese Thomas | Chief COMMERCIAL Off | M - OptEx | $0.00 | -938 | 2,812 | -25% | $0 |
| DM | 2022-03-10 | 2022-03-08 | ELUT | Englese Thomas | Chief COMMERCIAL Off | A - Grant | $0.00 | +55.1K | 31.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-03-08 | M | A | 938 | $0.00 | 6,883 | D | — | — | (F1) Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. (F2) Includes 857 shares of Class A Common Stock acquired under the Company's 2020 Employee Stock Purchase Plan. |
| 2 | Common | Class A Common Stock | 2022-03-10 | S | D | 276 | — | 6,607 | D | — | — | (F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.16 to $5.34. The Reporting Person undertakes to provide Aziyo Biologics, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| 3 | Derivative | Restricted Stock Units | 2022-03-08 | M | D | 938 | $0.00 | 2,812 | D | — · — to — | 938 Class A Common Stock | (F1) Restricted stock units convert into shares of Class A Common Stock on a one-for-one basis. (F7) On March 8, 2021, the Reporting Person was granted 3,750 restricted stock units, vesting in four substantially equal annual installments beginning in March 8, 2022. |
| 4 | Derivative | Restricted Stock Units | 2022-03-08 | A | A | 15,390 | $0.00 | 15,390 | D | — · — to — | 15,390 Class A Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. (F8) The restricted stock units vest on September 8, 2022, subject to the Reporting Person's continuous employment with the Issuer through such vesting date. |
| 5 | Derivative | Restricted Stock Units | 2022-03-08 | A | A | 8,700 | $0.00 | 8,700 | D | — · — to — | 8,700 Class A Common Stock | (F5) Each restricted stock unit represents a contingent right to receive one share of Issuer Class A Common Stock. (F6) The restricted stock units vest if the Issuer's Class A Common Stock achieves a price per share equal to or greater than $10.00 for any period of thirty (30) consecutive trading days prior to March 8, 2024. |
| 6 | Derivative | Stock Option (Right to Buy) | 2022-03-08 | A | A | 31,000 | $0.00 | 31,000 | D | $5.08 · — to 2032-03-08 | 31,000 Class A Common Stock | (F4) The option vests as to 25% of the shares on March 8, 2023 and in 12 equal quarterly installments thereafter, such that the option shall be fully vested and exercisable on March 8, 2026. |